These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23437240)

  • 1. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis.
    Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W
    PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis.
    Li L; Nie W; Zhou H; Yuan W; Li W; Huang W
    PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
    Li YY
    PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility.
    Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C
    Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis.
    Zhang X; Gao B; Xu B
    Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss.
    Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y
    Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis.
    Wei Z; Chang K; Fan C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population.
    Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ
    Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
    Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
    Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis.
    Zhang T; Pang C; Li N; Zhou E; Zhao K
    BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
    Lee YH; Song GG
    Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis.
    Xu X; Xie Y; Lin Y; Xu X; Zhu Y; Mao Y; Hu Z; Wu J; Chen H; Zheng X; Qin J; Xie L
    Exp Ther Med; 2012 Dec; 4(6):1127-1133. PubMed ID: 23226787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
    Xu K; Liu X; Yang F; Cui D; Shi Y; Shen C; Tang W; Yang T
    PLoS One; 2013; 8(11):e79150. PubMed ID: 24223897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.
    Nie W; Li B; Xiu QY
    PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis.
    Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J
    Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological significance of plasminogen activator inhibitor-1 promoter 4G/5G polymorphism in breast cancer: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    Arch Med Res; 2013 Jan; 44(1):39-45. PubMed ID: 23291383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis : A meta-analysis.
    Bae SC; Lee YH
    Z Rheumatol; 2020 Apr; 79(3):312-318. PubMed ID: 31428858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies.
    Zheng L; Li X; Song Q; Hou C; Chen X; Li B
    Int Arch Allergy Immunol; 2019; 180(4):255-263. PubMed ID: 31574527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Association of Plasminogen Activator Inhibitor Type 1 (PAI-1) Level and PAI-1 4G/5G Gene Polymorphism with the Formation and the Grade of Endometrial Cancer.
    Yıldırım ME; Karakuş S; Kurtulgan HK; Kılıçgün H; Erşan S; Bakır S
    Biochem Genet; 2017 Aug; 55(4):314-321. PubMed ID: 28303356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.